Congenital stromal corneal dystrophy in a Spanish family: Clinical, genetic and histological analysis

CONCLUSIONS: CSCD is a rare entity, which should be treated by DALK whenever possible, obtaining better results than PK. Close monitoring of children of affected individuals is important, because CSCD can progress during the early years of life.PMID:38484481 | DOI:10.1016/j.jfo.2024.104138

Source: Journal Francais d Ophtalmologie - March 14, 2024 Category: Opthalmology Authors: V G ómez-Calleja B Burgos-Blasco R M éndez-Fernández P P érez-García M Ari ño-Gutiérrez L Borrego-Sanz A M Colino Gallardo D D íaz-Valle Source Type: research